Your search returned 98 results.

Results
	1.	The breast cancer continuum: intersecting current and novel treatment strategies in clinical practice MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_363 Add to cart (remove)
	2.	Minor ABO incompatibility does not impact non-relapse mortality in T-cell depleted HLA-matched sibling transplantation MedStar authors: Chokshi, Puja DD Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Chokshi PD, Anandi P, Jain N, Dunavin N, Le RQ, Ito S, Barrett J, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	3.	HER 2 positive breast - standard of care treatment in 2015 and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Oct 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	4.	HER 2(+) new therapeutic alternatives in HER 2(+) breast cancer, Pregnancy in breast cancer, and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 27 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	5.	HER2 targeted therapy for breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Aug 6 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	6.	Cardiac safety monitoring in oncology trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Jul 30 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	7.	Treatments to beat breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 18 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	8.	HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 9 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	9.	State of the art in MBC MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 3 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	10.	Intensive CT scan surveillance for patients who have undergone curative intent treatment for colorectal cancer: The Medstar Washington Hospital Center experience MedStar authors: Leventakos, Konstantinos Lu, Stanlee Perry, David J Year: 2013 Institution: Washington Cancer Institute Form of publication: Conference All authors: Leventakos K, Lu S, Perry D Local accession number: 2013_3 Add to cart (remove)
	11.	HER 2 positive breast - standard of care treatment in 2015 and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Oct 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	12.	HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 9 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	13.	The optimal management of recurrent HER2 positive disease - diagnostic and treatment strategies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	14.	Is there an optimal treatment sequence for HER2 positive advanced breast cancer? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	15.	PALINA: A phase II safety study of palbociclib in combination with letrozole in African American women with hormone receptor positive HER2 negative advanced breast cancer. MedStar authors: Gallagher, Christopher Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Cai L Castle J Forero A Gallagher C Graham D Isaacs C Kamugisha L Lynce F Mohebtash M Novielli N Shajahan-Haq A Local accession number: A2017_337 Add to cart (remove)
	16.	Prognostic associations of tumor-infiltrating lymphocytes (TIL) in metastatic HER2-positive breast cancer (BC) treated with trastuzumab and pertuzumab: a secondary analysis of the CLEOPATRA study MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_346 Add to cart (remove)
	17.	Quality of life and toxicity outcomes for patients with early stage breast cancer treated with intra-operative radiation therapy: a prospective analysis MedStar authors: Costellic, C Gary, M Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Costellic C, Gulla A, Hechenbleikner E, Clarke J, Collins B, Rudra S, Chaldekas K, Seevaratnam S, Langan R, Gary M, Willey S, Tousimis E Local accession number: 2015_6 Add to cart (remove)
	18.	Role of cardiac CT as a screening test for CAD detection in long-term Allogeneic Stem Cell Transplant (allo-SCT) survivors MedStar authors: Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Jain NA, Chen MY, Shanbhag S, Anandi P, Lu K, Pophali P, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	19.	Late side-effects of breast cancer radiotherapy: second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Dec 8 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	20.	Breast cancer - HER2/ER MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 1 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	21.	Quality of life and toxicity outcomes for patients with early stage breast cancer treated with intra-operative radiation therapy: a prospective analysis MedStar authors: Costellic, C Gary, M Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Costellic C, Gulla A, Hechenbleikner E, Clarke J, Collins B, Rudra S, Chaldekas K, Seevaratnam S, Langan R, Gary M, Willey S, Tousimis E Local accession number: 2015_6 Add to cart (remove)
	22.	The optimal management of recurrent HER2 positive disease - diagnostic and treatment strategies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	23.	Breast cancer - HER2/ER MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 1 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	24.	Late side-effects of breast cancer radiotherapy: second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Dec 8 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	25.	Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_365 Add to cart (remove)
	26.	HRT: Can we be convinced of the impact on the risk of Breast Cancer? MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_366 Add to cart (remove)
	27.	Management of advanced breast cancer MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_356 Add to cart (remove)
	28.	Oral presentation skills Career Development Forum: A Networking Session for Young Investigators MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_344 Add to cart (remove)
	29.	Blood stream infection is frequent during conditioning but does not impact allogeneic transplant outcomes in the modern era MedStar authors: Chokshi, Puja DD Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Chokshi PD, Anandi P, Dunavin N, Jain N, Anand A, Le RQ, Ito S, Barrett J, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	30.	The optimal management of recurrent HER2 positive disease - diagnostic and treatment strategies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	31.	Effect of intervention on a quality measure of pain management at Medstar Washington Cancer Institute MedStar authors: Agrawal, Sundeep Chokshi, Puja D Jarin, J Ranpura Vishal, N Self, Linda Wood, L Yerasi, Charan Year: 2014 Citation: Unpublished 2014 May 6 Institution: Washington Cancer Institute Form of publication: Conference All authors: Ranpura VN, Chokshi P, Yerasi C, Agrawal S, Wood L, Harkness J, Self L, Jang S Local accession number: 2014.1_2 Add to cart (remove)
	32.	Minor ABO incompatibility does not impact non-relapse mortality in T-cell depleted HLA-matched sibling transplantation MedStar authors: Chokshi, Puja DD Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Chokshi PD, Anandi P, Jain N, Dunavin N, Le RQ, Ito S, Barrett J, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	33.	Role of cardiac CT as a screening test for CAD detection in long-term Allogeneic Stem Cell Transplant (allo-SCT) survivors MedStar authors: Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Jain NA, Chen MY, Shanbhag S, Anandi P, Lu K, Pophali P, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	34.	Current and future treatment of HER2 positive breast cancer: expert advice for clinicians MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	35.	Is there an optimal treatment sequence for HER2 positive advanced breast cancer? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	36.	Breast cancer - HER2/ER MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 1 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	37.	HER2 targeted therapy for breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Aug 6 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	38.	Cardiac safety monitoring in oncology trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Jul 30 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	39.	HER 2 positive breast - standard of care treatment in 2015 and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Oct 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	40.	HER2 targeted therapy for breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Aug 6 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	41.	State of the art in MBC MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 3 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	42.	HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 9 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	43.	A randomized, double-blinded, placebo-controlled clinical trial to evaluate extended adjuvant endocrine therapy (5 years of letrozole) in postmenopausal women with hormone-receptor positive breast cancer who have completed previous adjuvant endocrine therapy: initial results of NRG oncology/NSABP B-42 MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_345 Add to cart (remove)
	44.	Update on treatment of HER2 positive advanced breast cancer MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_354 Add to cart (remove)
	45.	Biological characterization and adjuvant algorithms MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_355 Add to cart (remove)
	46.	Pre-operative therapy for HER2 positive disease The role of combining anti-HER2 therapies - a paradigm shift MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_360 Add to cart (remove)
	47.	Update on treatment of HER2 positive advanced breast cancer MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_361 Add to cart (remove)
	48.	Is there an optimal treatment sequence for HER2-positive advanced breast cancer? MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_362 Add to cart (remove)
	49.	Is there an optimal treatment sequence for HER2 positive advanced breast cancer? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	50.	Approach to HER2+ advanced disease MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 12 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	51.	Blood stream infection is frequent during conditioning but does not impact allogeneic transplant outcomes in the modern era MedStar authors: Chokshi, Puja DD Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Chokshi PD, Anandi P, Dunavin N, Jain N, Anand A, Le RQ, Ito S, Barrett J, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	52.	Late side-effects of breast cancer radiotherapy: second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Dec 8 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	53.	Breast cancer- a global disease requiring an individualized approach and HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	54.	Treatments to beat breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 18 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	55.	Role of cardiac CT as a screening test for CAD detection in long-term Allogeneic Stem Cell Transplant (allo-SCT) survivors MedStar authors: Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Jain NA, Chen MY, Shanbhag S, Anandi P, Lu K, Pophali P, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	56.	Late side-effects of breast cancer radiotherapy: second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Dec 8 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	57.	Current and future treatment of HER2 positive breast cancer: expert advice for clinicians MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	58.	Cardiac safety monitoring in oncology trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Jul 30 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	59.	Approach to HER2+ advanced disease MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 12 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	60.	Cardiac safety monitoring in oncology trials MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Jul 30 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	61.	Treatments to beat breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 18 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	62.	Gastric cancer: experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors: Ihemelandu, Chukwuemeka Year: 2018 Institution: Washington Cancer Institute Form of publication: Conference All authors: Ihemelandu CU. Local accession number: B2018520 Add to cart (remove)
	63.	Module 7: Breast cancer; research to practice MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_352 Add to cart (remove)
	64.	Management of axillary positive nodes (1 to 3 nodes) in invasive breast cancer MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_357 Add to cart (remove)
	65.	Breast cancer HER2/ER+ MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_358 Add to cart (remove)
	66.	ASCO's female past presidents: how to manage it all? MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_359 Add to cart (remove)
	67.	HER2 positive breast cancer: updates in metastatic disease MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_364 Add to cart (remove)
	68.	What are the obstacles for female careers in oncology? MedStar authors: Swain, Sandra M Year: 2016 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain SM Local accession number: 2016_353 Add to cart (remove)
	69.	Current and future treatment of HER2 positive breast cancer: expert advice for clinicians MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	70.	Breast cancer- a global disease requiring an individualized approach and HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	71.	HER 2(+) new therapeutic alternatives in HER 2(+) breast cancer, Pregnancy in breast cancer, and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 27 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	72.	Approach to HER2+ advanced disease MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 12 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	73.	State of the art in MBC MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 3 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	74.	Is there an optimal treatment sequence for HER2 positive advanced breast cancer? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	75.	Breast cancer- a global disease requiring an individualized approach and HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	76.	Treatments to beat breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 18 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	77.	HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 9 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	78.	Role of cardiac CT as a screening test for CAD detection in long-term Allogeneic Stem Cell Transplant (allo-SCT) survivors MedStar authors: Jain, N Year: 2015 Citation: Unpublished 2015 May 5 Institution: Washington Cancer Institute Form of publication: Conference All authors: Jain NA, Chen MY, Shanbhag S, Anandi P, Lu K, Pophali P, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M Local accession number: 2015_1 Add to cart (remove)
	79.	Current and future treatment of HER2 positive breast cancer: expert advice for clinicians MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Nov 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	80.	HER 2 positive breast - standard of care treatment in 2015 and Are we ready to individualize chemotherapy by breast cancer subtype? MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Oct 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	81.	The optimal management of recurrent HER2 positive disease - diagnostic and treatment strategies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 17 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	82.	Breast cancer - HER2/ER MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Sep 1 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	83.	HER2 targeted therapy for breast cancer MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Aug 6 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	84.	Breast cancer- a global disease requiring an individualized approach and HER 2- targeted therapies MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Apr 24 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	85.	Approach to HER2+ advanced disease MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 12 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	86.	State of the art in MBC MedStar authors: Swain, Sandra M Year: 2015 Citation: Unpublished 2015 Feb 3 Institution: Washington Cancer Institute Form of publication: Conference All authors: Swain S Local accession number: 2015_3 Add to cart (remove)
	87.	Pilot project to determine the predictive value of microRNAs in breast cancer brain metastases MedStar authors: Desale, Sameer Herbolsheimer, Pia M Lucas, Zarah Year: 2015 Citation: Unpublished 2015 May 5 Institution: MedStar Health Research Institute Washington Cancer Institute Form of publication: Conference All authors: Lucas Z, Shivapurkar N, Desale S, Wellstein A, Herbolsheimer P Local accession number: 2015_3 Add to cart (remove)
	88.	Pilot project to determine the predictive value of microRNAs in breast cancer brain metastases MedStar authors: Desale, Sameer Herbolsheimer, Pia M Lucas, Zarah Year: 2015 Citation: Unpublished 2015 May 5 Institution: MedStar Health Research Institute Washington Cancer Institute Form of publication: Conference All authors: Lucas Z, Shivapurkar N, Desale S, Wellstein A, Herbolsheimer P Local accession number: 2015_3 Add to cart (remove)
	89.	Treatment of Enchondrosarcomas of the Distal Femur MedStar authors: Adams, Brock Henshaw, Robert Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Orthopedic Oncology Form of publication: Conference All authors: Adams B, Iofin I, Henshaw R Local accession number: 2013_4 Add to cart (remove)
	90.	Effect of Intervention on a Quality Measure of Pain Management at MedStar Washington Cancer Institute (MWCI) MedStar authors: Heller, Stephanie Jang, Sekwon Ranpura, Vishal Self, Linda Wood, Lynne Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Hematology and Oncology Form of publication: Conference All authors: Ranpura V, Jang A, Wood L, Heller S, Self L Local accession number: 2013_5 Add to cart (remove)
	91.	Robotic-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy for Locally Advanced Prostate Cancer: A Multi-Institution Comparison of Oncologic Outcomes MedStar authors: Bandi, Gaurav Ghasemian, Seyem Reza Hwang, Jonathan Kowalczyk, Keith Lynch, John McGeagh, Kevin Nissim, Hanaa G Venkatesan, Krishnan Verghese, Mohan Vora, Anup Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Urology Form of publication: Conference All authors: Vora A, Nissim H, Kowalczyk K, McGeagh K, Bandi G, Lynch J, Borges P, Venkatesan K, Ghasemian R, Verghese M, Hwang J Local accession number: 2013_63 Add to cart (remove)
	92.	Multi-Institutional Predictors of Gleason Score Upgrading in a Large African-American Population MedStar authors: Bandi, Gaurav Ghasemian, Seyem Reza Harbin, Andrew Hwang, Jonathan Kowalczyk, Keith Lynch, John McGeagh, Kevin Nissim, Hanaa G Venkatesan, Krishnan Verghese, Mohan Vora, Anup Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Urology Form of publication: Conference All authors: Vora A, Nissim H, Harbin A, Kowalczyk K, Bandi G, McGeagh K, Lynch J, Venkatesan K, Ghasemian R, Verghese M, Hwang J Local accession number: 2013_62 Add to cart (remove)
	93.	Pilot project to determine the predictive value of microRNAs in breast cancer brain metastases MedStar authors: Desale, Sameer Herbolsheimer, Pia M Lucas, Zarah Year: 2015 Citation: Unpublished 2015 May 5 Institution: MedStar Health Research Institute Washington Cancer Institute Form of publication: Conference All authors: Lucas Z, Shivapurkar N, Desale S, Wellstein A, Herbolsheimer P Local accession number: 2015_3 Add to cart (remove)
	94.	Can Medicaid expansion decrease disparity in surgical cancer care at high quality hospitals? MedStar authors: Ihemelandu, Chukwuemeka Shara, Nawar Year: 2017 Institution: MedStar Health Research Institute Washington Cancer Institute Form of publication: Conference All authors: Al-Refaie W DeLeire T Ihemelandu C Jindal M Johnson L Shara N Xiao D Zheng C Local accession number: A2017_417 Add to cart (remove)
	95.	Pilot project to determine the predictive value of microRNAs in breast cancer brain metastases MedStar authors: Desale, Sameer Herbolsheimer, Pia M Lucas, Zarah Year: 2015 Citation: Unpublished 2015 May 5 Institution: MedStar Health Research Institute Washington Cancer Institute Form of publication: Conference All authors: Lucas Z, Shivapurkar N, Desale S, Wellstein A, Herbolsheimer P Local accession number: 2015_3 Add to cart (remove)
	96.	Comparing the Efficacies of Neoadjuvant Non-Cisplatin and Cisplatin Based Chemotheraies in Obtaining Pathologic Complete Remissions in Muscle Invasive Bladder Cancer MedStar authors: Perry, David J Ranpura, Vishal Sivakumaran, Praveen Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Hematology and Oncology Form of publication: Conference All authors: Ranpura V, Sivakumaran P, Perry DJ Local accession number: 2013_5 Add to cart (remove)
	97.	Accuracy of Initial Shave Biopsy as a Predictor of Final Stage after Definitive Treatment in Patients with Melanoma MedStar authors: Khanna, Sarika Peck, Gary L Venna, Suraj S Wenk, Kurt S Year: 2013 Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Dermatology Form of publication: Conference All authors: Wenk K, Khanna S, Peck GL, Venna SS Local accession number: 2013_3 Add to cart (remove)
	98.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)

Refine your search

Authors

Item types

Collections

Languages

Your search returned 98 results.